Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 20% ± 1% | |
GABAergic neuron | 3 studies | 23% ± 1% | |
glutamatergic neuron | 3 studies | 28% ± 6% |
Insufficient scRNA-seq data for expression of COQ6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 332.26 | 1445 / 1445 | 100% | 2.47 | 183 / 183 |
liver | 100% | 327.23 | 226 / 226 | 100% | 3.01 | 406 / 406 |
prostate | 100% | 400.24 | 245 / 245 | 100% | 4.70 | 502 / 502 |
thymus | 100% | 437.94 | 653 / 653 | 100% | 2.89 | 604 / 605 |
ovary | 100% | 376.07 | 180 / 180 | 100% | 3.17 | 429 / 430 |
intestine | 100% | 375.06 | 966 / 966 | 100% | 2.73 | 525 / 527 |
adrenal gland | 100% | 1039.28 | 258 / 258 | 100% | 4.01 | 229 / 230 |
bladder | 100% | 402.67 | 21 / 21 | 99% | 2.93 | 501 / 504 |
breast | 100% | 413.61 | 459 / 459 | 99% | 3.71 | 1111 / 1118 |
uterus | 100% | 389.60 | 170 / 170 | 99% | 2.94 | 456 / 459 |
stomach | 100% | 326.98 | 359 / 359 | 99% | 2.47 | 284 / 286 |
kidney | 100% | 447.93 | 89 / 89 | 99% | 3.18 | 894 / 901 |
brain | 99% | 282.22 | 2624 / 2642 | 100% | 3.06 | 704 / 705 |
skin | 100% | 300.34 | 1808 / 1809 | 99% | 2.51 | 465 / 472 |
lung | 98% | 255.79 | 569 / 578 | 99% | 2.60 | 1146 / 1155 |
pancreas | 97% | 137.45 | 319 / 328 | 97% | 2.48 | 172 / 178 |
adipose | 100% | 351.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 324.54 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2.32 | 29 / 29 |
muscle | 100% | 515.38 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 360.76 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.44 | 1 / 1 |
heart | 99% | 502.83 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 3.00 | 76 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 2.16 | 41 / 45 |
peripheral blood | 65% | 123.10 | 601 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006744 | Biological process | ubiquinone biosynthetic process |
GO_0042995 | Cellular component | cell projection |
GO_0031314 | Cellular component | extrinsic component of mitochondrial inner membrane |
GO_0110142 | Cellular component | ubiquinone biosynthesis complex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0071949 | Molecular function | FAD binding |
GO_0016709 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO_0008681 | Molecular function | 2-octaprenyl-6-methoxyphenol hydroxylase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0005515 | Molecular function | protein binding |
GO_0106364 | Molecular function | 4-hydroxy-3-all-trans-hexaprenylbenzoate oxygenase activity |
Gene name | COQ6 |
Protein name | Coenzyme Q6, monooxygenase Coenzyme Q6 homolog, monooxygenase (Yeast), isoform CRA_a (Coenzyme Q6, monooxygenase) Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6) |
Synonyms | CGI-10 hCG_21715 |
Description | FUNCTION: FAD-dependent monooxygenase required for the C5-ring hydroxylation during ubiquinone biosynthesis. Catalyzes the hydroxylation of 3-hexaprenyl-4-hydroxybenzoic acid (HHB) to 3-hexaprenyl-4,5-dihydroxybenzoic acid (DHHB). The electrons required for the hydroxylation reaction may be funneled indirectly from NADPH via a ferredoxin/ferredoxin reductase system to COQ6 (By similarity). Is able to perform the deamination reaction at C4 of 3-hexaprenyl-4-amino-5-hydroxybenzoic acid (HHAB) to produce DHHB when expressed in yeast cells lacking COQ9, even if utilization of para-aminobenzoic acid (pABA) involving C4-deamination seems not to occur in bacteria, plants and mammals, where only C5 hydroxylation of HHB has been shown . . |
Accessions | Q9Y2Z9 A0A0D9SFJ1 ENST00000334571.7 [Q9Y2Z9-1] G3V4A6 G3V2L5 G3V3A1 ENST00000554341.6 ENST00000629426.2 ENST00000554920.5 ENST00000554320.1 ENST00000394026.8 [Q9Y2Z9-3] ENST00000555196.5 ENST00000557584.5 G3V3L0 G3V434 |